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ABSTRACT 
Metronidazole is an antibiotic that is used to treat a wide variety of infections. It works by stopping the growth of certain bacteria and parasites. This 
antibiotic treats only certain bacterial and parasitic infections. It may also be used with other medications to treat certain stomach/intestinal ulcers 
caused by bacteria (H. pylori). A transferosome is the first generation of an elastic liposome prepared from phospholipids and edge activators. An 
edge activator is often a single-chain surfactant with a high radius of curvature that destabilizes the lipid bilayers of vesicles and increases the 
deformability of the bilayers, thereby making the vehicle ultra-deformable. The aim of the present study was to investigate the potential of 
transfersomal gel formulations for transdermal delivery of metronidazole and to evaluate the effect of lipid concentration, ethanol 
concentration, drug concentration and stirrer time. Characterization of transfersomes performed by vesicle size, surface charge, entrapment 
efficiency and zeta potential. Characterization of transfersome containing gel performed by the measurement of viscosity, drug content, 
extrudability study, spreadability and in vitro drug diffusion study. It was found that viscosity of prepared gel was 3560cps, % assay was 
98.89±0.45, extrudability was 1156g and spreadibility (g.cm/sec) was found that 11.23(g.cm/sec) respectively.  In vitro drug release from 
transfersomes gel was carried out using Franz diffusion cell method and found 85.56% in 12 hr. In first 30 min it was 22.2 % drug release which 
slightly high. It was due to the release of free drug present in bag after leaching from transfersomes. Drug release from transferosomal gel 
formulation was found in very sustained and controlled manner. The results were obtained which showed that transfersomal gel was a 
promising candidate for transdermal delivery with targeted and prolonged release of a drug. It also enhances skin permeation of many drugs. 
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INTRODUCTION 
Metronidazole is one of the most preferred drug of choice for 
intestinal amoebiasis, giardiasis, trichomoniasis, bacterial 
vagi-nosis, surgical infections and duodenal ulcer associated 
with Helicobacter pylori infections, etc1,2. Metronidazole is 
slightly soluble in water and is usually about 80% absorbed 
orally, although absorption in some patients can be much 
lower3. Conventional tablets of metronidazole provide 
minimal amount of drug for the local action in colon, still 
resulting in the relief of amoebiasis, but with systemic side 
effects4. The minimum inhibitory concentration and 
bactericidal concentration of me-tronidazole is 3.1 and 6.3 
mg/ml, respectively5. Metronidazole dosing regimens often 
include sets of daily doses extending over periods of several 
weeks. Since the elimination halftime of metronidazole is 6–
8 h; the drug has to be taken 3–4 times per day in order to 
maintain the desired therapeutic level. Site specific and 
controlled release dosage forms will prolong the residence 
time and improve bioavailability6. Hence, alternate dosage 
forms in which metronidazole is released slowly from a drug 
carrier have been suggested as a means to reduce dosing 
frequency and systemic toxicity7,8. Nanotechnology involves 
fabrication of nanoscale structures which are observed 
visibly under high resolution. These molecular assemblies 
are especially designed for attaining their target functions9. 
Based on their critical packing parameter and hydrophilic 
lipophilic balance (HLB), these molecules are self-assembled 
to various morphologies including micelles, sheets and 
vesicles (liposomes, transferosomes, exsosomes, niosomes 
etc.) 10. Furthermore, these vesicular formulations had been 
more exploited in the field of transdermal drug delivery11. 
They offer many advantages over conventional delivery 
systems like bio-compatibility, non-toxicity and ability to 
modify drugs’ bioavailability12. In addition to the utilization 
of vesicular carriers for transdermal drug delivery, 
nanotransfection approaches (TNT) have been recently 
introduced for topical and controllable delivery of 
reprogramming factors across the skin. These approaches 
allow delivery of controlling factors by applying intense and 
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highly focused electric field using arrayed nano-channel. 
Hence, TNT can deliver the cargo to skin in rapid and non-
invasive manner13. In this manuscript, the strategy of using 
transferosome s as a vesicular nano-carrier has been 
selected and investigated for efficient transdermal delivering 
of drugs and bypassing their oral problems. Transferosomes 
are ultra-flexible vesicles with a bilayer structure. They can 
penetrate the skin easily and overcome the barrier function 
by squeezing through the intracellular lipid of the stratum 
corneum14. After application of Transferosomes on the skin, 
they move from the dry stratum corneum to a deep hydrated 
layer according to the osmotic gradient. The presence of 
surfactant in their structure helps in solubilizing the lipid in 
stratum corneum and permits high penetration of the 
vesicles15. In the present investigation, we attempted to 
develop and optimize transferosomal gel containing 
metronidazole, for improved transdermal permeation.  
MATERIALS AND METHODS 
Materials 
Metronidazole and Soya PC was purchased from Himedia 
Laboratory, Mumbai. Ethanol, chloroform and carbopol-934 
purchased from CDH chemical Pvt. Ltd. New Delhi. Dialysis 
membrane of Mol Wt cutoff 1200 was purchased from 
Himedia Laboratory, Mumbai. Demineralized and double 
distilled water was prepared freshly and used whenever 
required. All other reagents and chemicals used were of 
analytical grade. 
Methods 
Determination of λ max of metronidazole  
Accurately weighed 10 mg of drug was dissolved in 10 ml of 
7.4 pH buffer solution in 10 ml of volumetric flask. The 
resulted solution 1000µg/ml and from this solution 1 ml 
pipette out and transfer into 10 ml volumetric flask and 
volume make up with 7.4 pH buffer solution.  Prepare 
suitable dilution to make it to a concentration range of 5-
25μg/ml. The spectrum of this solution was run in 200-400 
nm range in U.V. spectrophotometer (Labindia-3000+). A 
graph of concentration Vs absorbance was plotted. 
Preparation of metronidazole loaded transfersomes 
Soya PC (0.5, 1.0, 1.5, 2.0% w/v) was dissolved in ethanol (5-
25% v/v) and heated up to 30±1°C in a water bath in a 
closed vessel16. Distilled water or drug solution in distilled 
water (1% w/v solution), which is previously heated up to 
30±1°C, was added slowly in a fine stream to the above 
ethanolic lipid solution with continuous mixing using a 
magnetic stirrer at 900 rpm. Mixing was continued for 
another 5 minutes and finally, the vesicular dispersions 
resulted was left to cool at room temperature (25±1°C) for 
45 minutes.  
Optimization of transfersomes formulation 
Transfersomes formulation optimized based on the 
evaluation of mentioned strategy procedure resting on the 
source of average vesicle size and (%) entrapment efficiency 
(EE). In the transfersomal formulation, the ratio of lipid was 
optimized by taking their different ratio such as 0.5, 1.0, 1.5, 
and 2.0% w/v ratio and all other parameters were kept 
remain constant. the ethanol content was optimized by 
taking their different quantity such as 5, 10, 15 and 20 and 
all other parameters were kept remain constant. Drug 
concentration optimized by taking different concentration of 
drug such as 1, 1.5, and 2.0% w/v and prepared their 
formulation and all other parameters such as Soya PC, 
stirrer time kept remain constant. Stirrer time was 
optimized by stirring the formulation for different time, i.e., 
5, 10, and 15 min. 
Characterization of metronidazole-loaded transfersomes 
Microscopic observation of prepared transferosomes 
An optical microscope (cippon, Japan) with a camera 
attachment (Minolta) was used to observe the shape of the 
prepared transferosomes formulation.  
Surface charge and vesicle size 
The vesicles size and size distribution and surface charge 
were determined by Dynamic Light Scattering method (DLS) 
(Malvern Zetamaster, ZEM 5002, Malvern, UK). 
Zeta potential 
The zeta potential was calculated according to Helmholtz–
Smoluchowsky from their electrophoretic mobility. For 
measurement of zeta potential, a zetasizer was used with 
field strength of 20 V/cm on a large bore measures cell. 
Samples were diluted with 0.9% NaCl adjusted to a 
conductivity of 50 lS/cm. 
Entrapment efficiency 
Entrapment efficiency was determined by measuring the 
concentration of unentrapped free drug in aqueous medium. 
About 1 ml of the drug loaded transfersomes dispersion was 
placed in the Ependorf tubes and centrifuged at 17000 rpm 
for 30 min. The transfersomes along with encapsulated drug 
were separated at the bottom of the tubes. Plain 
transfersomes without drug was used as blank sample and 
centrifuged in the same manner. In order to measure the 
free drug concentration, the UV absorbance of the 
supernatant was determined at 278 nm. 
Preparation of gel base carbopol 
Carbopol 934 (1%w/v) was accurately weighed and 
dispersed into double distilled water (80ml) in a beaker. 
This solution was stirred continuously at 800 rpm for 1 hour 
and then 10ml of propylene glycol was added to this 
solution. Volume of gel was adjusted to 100 ml and then 
sonicated for 10 min on bath sonicator to remove air 
bubbles. Final pH of the gel base was adjusted to 6.5. 
Transferosomal preparation corresponding to 2% w/w of 
Metronidazole was incorporated into the gel base to get the 
desired concentration of drug in gel base. 
Characterization of transfersomes containing gel 
Measurement of viscosity  
Viscosity measurements of prepared topical transfersomes 
based gel were measured by Brookfield viscometer using 
spindle no. 63 with the optimum speed of 10 rpm.  
pH measurements  
The pH of selected optimized formulations was established 
with the help of digital pH meter. The pH meter was 
calibrated with the help of buffer solution of pH 4, pH 7 and 
pH 9. After calibration, the electrode was dipped into the 
vesicles. Then, pH of selected formulation was measured and 
readings shown on display were noted. 
Drug content 
Accurately weighed 100 mg of topical transferosomal gel 
was taken in beaker and added 20 ml of methanol. This 
solution was mixed thoroughly and filtered by means of 
Whatman filter paper No. 1. Then, 1.0 ml of filtered solution 
was engaged in 10 ml capacity of volumetric flask; moreover, 
volume was ready up to 10 ml by means of methanol. This 
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solution was analyzed using UV spectrophotometer at λmax 
278 nm.  
Extrudability study  
Extrudability was determined on the amount of the gel 
extruded as of collapsible tube on appliance of certain load. 
More the quantity of gel extruded shows better 
extrudability. It was determined by applying the weight on 
gel filled collapsible tube and recorded the weight on which 
gel was extruded from tube. 
Spreadability 
Spreadability of formulation is necessary to provide 
sufficient dose available to absorb from skin to get good 
therapeutic response. An apparatus in which a slide fixed on 
wooden block and upper slide has movable and one end of 
movable slide tied with weight pan. To determine 
spreadability, 2-5 gm of gel placed between two slides and 
gradually weight was increased by adding it on the weight 
pan and time required with the top plate to face the distance 
of 10 cm on adding 80 g of weight was noted. Good 
spreadability shows lesser time to spread. It is determine by 
formula given below17. 
  
   
 
 
Where, S=Spreadability (gcm/sec), m = weight tied to the 
upper slide (20 grams),  
l= length of glass slide (6cms), t = time taken is seconds. 
In vitro drug diffusion study  
The in vitro diffusion study about is conveyed by utilizing 
Franz diffusion cell. Egg membrane is taken as semi 
penetrable membrane for diffusion18. The Franz diffusion 
cell has receptor compartment with an effective volume 
roughly 60 ml and compelling surface area of permeation 
3.14sq.cm. The egg membrane is placed between the donor 
and the receptor compartment. A 2cm2 size patch taken and 
weighed then set on one face of membrane confronting 
donor compartment. The receptor medium is phosphate 
buffer pH 7.4. The receptor compartment is encompassed 
through water casing to keep up the temperature at 32 ± 
0.5°C. Warmth is furnished utilizing a thermostatic hot plate 
with a magnetic stirrer. The receptor liquid is mixed by 
Teflon covered magnetic bead which is put in the diffusion 
cell. Amid each testing interim, samples are pulled back and 
replaced by equivalent volumes of fresh receptor liquid on 
each sampling. The samples withdrawn are analyzed 
spectrophotometrically at wavelength of drug 278 nm. 
RESULTS AND DISCUSSIONS 
The absorption maxima of metronidazole were determined 
by running the spectrum of drug solution in double beam 
ultraviolet spectrophotometer (Labindia UV 3000+) using 
concentration range of 5-25μg/ml metronidazole in 
7.4phosphate buffers Figure1. Metronidazole showed a 
linear relationship with correlation coefficient of 0.999 in 
the concentration range of 5-25μg/ml in phosphate buffer 
pH 7.4. All the data of preformulation study were found 
similar as given in standard monograph which confirmed 
that the drug was authenticated and pure in form and it 
could be used for formulation development of metronidazole 
loaded transfersomes. Optimization of the transfersomes to 
generate the formulation code was done using the strategy 
as reflected in Table 1 optimization of lipid concentration, 
Table 2 optimization of ethanol concentration, Table 3 
optimization of drug concentration and Table 4 optimization 
of stirrer time. It was observed that the vesicles dimension 
of transfersomes was increased with raising the 
concentration of phosphatidylcholine and ethanol. There 
was no noteworthy difference observed in average vesicle 
size with increasing the drug concentration, but with 
increase in the stirrer time the size of vesicle decreased from 
145.56to 132.23after 15 min of stirring. Considering the EE, 
it was observed that the percent drug entrapment increased 
with escalating the concentration of ethanol and on 
escalating the time of stirring. The resulted formulation code 
F-14 was considered as the optimized formulation. The 
average vesicle size of optimized formulation (F-14) 
observed as 132.23 nm, zeta potential observed as -24.12mV 
and %EE was found as 71.12%. Prepared gel of 
transfersomes loaded with metronidazole (TG-14) was 
prepared and evaluated for viscosity, pH, % drug content, 
extrudability, spreadability and drug release study (Table 5). 
It was found that viscosity of prepared gel TG-14 was 
3560cps, % assay was 98.89±0.45%, extrudability was 156g 
and spreadibility (g.cm/sec) was found that 11,23(g.cm/sec) 
respectively.  In vitro drug release from Transfersomes was 
carried out using Franz diffusion cell method and found 
85.56% in 12 hr. In first 30 min it was 22.2% drug release 
which slightly high. It was due to the release of free drug 
present in bag after leaching from Transfersomes. Drug 
release from transferosomal formulation was found in very 
sustained and controlled manner. 
 
Figure 1 Wavelength maxima of metronidazole in 
phosphate buffer pH 7.4
 
Table 1 Optimization of lipid concentration 
Formulation code 
Soya PC 
(% w/v) 
Ethanol 
Drug 
(% w/v) 
Average vesicle 
size (nm) 
% entrapment 
efficiency 
F1 0.5 10 1.0 320.23 65.56 
F2 1.0 10 1.0 285.65 70.23 
F3 1.5 10 1.0 266.54 65.52 
F4 2.0 10 1.0 295.56 48.89 
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Table 2 Optimization of ethanol concentration 
Formulation 
code 
Soya PC 
(% w/v) 
Ethanol 
Drug 
(% w/v) 
Average vesicle 
size (nm) 
% entrapment 
efficiency 
F5 1.0 5 1.0 275.56 65.25 
F6 1.0 10 1.0 210.23 72.23 
F7 1.0 15 1.0 265.56 69.98 
F8 1.0 20 1.0 274.45 65.23 
 
Table 3Optimization of drug concentration 
Formulation code 
Soya PC 
(% w/v) 
Drug 
(% w/v) 
Ethanol 
(ml) 
Average vesicle 
size (nm) 
% Entrapment 
efficiency 
F9 1.0 1.0 10 210.12 78.25 
F10 1.0 1.5 10 265.56 65.23 
F11 1.0 2.0 10 295.45 45.58 
 
Table 4 Optimization of Stirrer time 
Formulation code 
Soya PC:  
(% w/v) 
Drug 
(% w/v) 
Stirrer 
time 
(min) 
Average vesicle 
size (nm) 
% Entrapment 
efficiency 
F12 1.0 1.0 5 145.56 45.56 
F13 1.0 1.0 10 165.58 62.23 
F14 1.0 1.0 15 132.23 71.12 
 
Table 5 Characterization of gel based formulation of prepared gel containing metronidazole loaded Transfersomes 
Gel 
TG-14 
Viscosity Assay Extrudability Spreadability 
3560cps 98.89±0.45% 156g 11.23(g.cm/sec) 
 
CONCLUSION 
Transfersomes were prepared and optimized on the base of 
average vesicle size and % drug entrapment. The optimized 
formulation was further incorporated with gel base 
(Carbopol gel) and characterized for their viscosity, pH, % 
drug content, extrudability, spreadability and drug release 
study. The average vesicle size of optimized formulation (F-
14) observed as 132.23 nm, zeta potential observed as -
24.12mV and %EE was found as 71.12%. It can be concluded 
that prepared gel containing metronidazole -loaded 
transfersomal formulation was optimized and can be of use 
for topical preparation. 
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